当前位置:首页 - 行情中心 - 华恒生物(688639) - 财务分析 - 现金流量表

华恒生物

(688639)

  

流通市值:62.07亿  总市值:67.87亿
流通股本:2.28亿   总股本:2.50亿

现金流量表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金1,491,262,060.07969,862,705.67487,111,243.252,003,986,829.22
收到的税费返还136,549,820.5443,687,160.6322,669,728.1978,337,510.61
收到其他与经营活动有关的现金33,887,18016,980,054.723,719,251.4215,464,315.95
经营活动现金流入的平衡项目0000
经营活动现金流入小计1,661,699,060.611,030,529,921.02513,500,222.862,097,788,655.78
购买商品、接受劳务支付的现金1,181,141,558.2695,877,081.98514,444,028.231,414,918,234.98
支付给职工以及为职工支付的现金211,290,777.46137,617,472.7672,523,426.06159,219,667.62
支付的各项税费35,150,250.1128,956,328.247,660,821.4289,779,668.23
支付其他与经营活动有关的现金129,509,846.4885,105,565.9422,287,692.7132,453,869.6
经营活动现金流出的平衡项目0000
经营活动现金流出小计1,557,092,432.25947,556,448.92616,915,968.411,796,371,440.43
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额104,606,628.3682,973,472.1-103,415,745.55301,417,215.35
二、投资活动产生的现金流量:
收回投资收到的现金---200,000,000
取得投资收益收到的现金---2,860,577.78
处置固定资产、无形资产和其他长期资产收回的现金净额76,82360,25018,3006,593,911
收到的其他与投资活动有关的现金13,633,071.2610,523,2482,730,0005,060,796.95
投资活动现金流入的平衡项目0000
投资活动现金流入小计13,709,894.2610,583,4982,748,300214,515,285.73
购建固定资产、无形资产和其他长期资产支付的现金626,000,987.17436,211,520.36190,643,326.451,269,164,957.18
投资支付的现金8,100,0008,100,0006,100,00072,400,033.33
支付其他与投资活动有关的现金11,015,0008,735,0004,330,000-
投资活动现金流出的平衡项目0000
投资活动现金流出小计645,115,987.17453,046,520.36201,073,326.451,341,564,990.51
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-631,406,092.91-442,463,022.36-198,325,026.45-1,127,049,704.78
三、筹资活动产生的现金流量:
吸收投资收到的现金5,318,678.75,318,678.7-7,091,571.6
取得借款收到的现金1,404,015,794.15828,053,170.92459,077,480.641,412,328,206.81
筹资活动现金流入平衡项目0000
筹资活动现金流入小计1,409,334,472.85833,371,849.62459,077,480.641,419,419,778.41
偿还债务支付的现金616,088,269.19407,383,401.18119,719,401.18246,336,000
分配股利、利润或偿付利息支付的现金170,403,346.7220,881,896.9310,391,961.39108,887,488.18
支付其他与筹资活动有关的现金12,886,137.5412,886,137.5412,362,407.5439,584,147.01
筹资活动现金流出平衡项目0000
筹资活动现金流出小计799,377,753.45441,151,435.65142,473,770.11394,807,635.19
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额609,956,719.4392,220,413.97316,603,710.531,024,612,143.22
四、汇率变动对现金及现金等价物的影响9,654,463.178,317,616.573,069,171.516,540,841.69
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额92,811,718.0241,048,480.2817,932,110.04205,520,495.48
加:期初现金及现金等价物余额352,494,098.78352,494,098.78352,494,098.78146,973,603.3
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额445,305,816.8393,542,579.06370,426,208.82352,494,098.78
补充资料:
净利润-147,992,111.97-446,599,806.18
资产减值准备-183,649.98-2,942,242.87
固定资产和投资性房地产折旧-64,965,992.13-96,025,686.98
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-64,965,992.13-96,025,686.98
无形资产摊销-1,544,940.12-2,810,027.14
处置固定资产、无形资产和其他长期资产的损失-66,998.76-5,224.18
固定资产报废损失-78,926.39-2,662,406.94
公允价值变动损失---313,237.93
财务费用-8,272,606.66-4,097,377.65
投资损失-51,080.29--2,860,577.78
递延所得税-6,452,034.63-8,675,111.04
其中:递延所得税资产减少--12,415,405.71--8,910,576.59
递延所得税负债增加-18,867,440.34-17,585,687.63
存货的减少--36,257,068.09--173,521,490.47
经营性应收项目的减少--13,781,710.26--89,695,422.93
经营性应付项目的增加--96,074,493.95--18,084,759.85
其他---21,044,900
现金的期末余额-393,542,579.06-352,494,098.78
减:现金的期初余额-352,494,098.78-146,973,603.3
公告日期2024-10-292024-08-282024-04-222024-04-22
审计意见(境内)标准无保留意见
TOP↑